Skip to main content

Table 4 Number of lines of subsequent systemic treatments

From: The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole

Number of treatments

Tamoxifen patients

Letrozole patients

0 (n = 47)

22

25

1 (n = 28)

13

15

2 (n = 16)

6

10

3 (n = 4)

0

4

4 (n = 2)

2

0